Results 111 to 120 of about 2,607 (202)

Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion

open access: yesAnti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
Bullous pemphigoid (BP) mainly targets type XVII collagen (COL17). Intravenous immunoglobulin (IVIg) is used to treat numerous autoimmune diseases, including BP. The major mechanism of action for IVIG is thought to be its immunomodulatory effect. However, little is known about the precise mechanisms of IVIg in BP. We investigate the cellular effects of
openaire  

Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid

open access: green, 2020
Steven D. Shapiro   +10 more
openalex   +1 more source

A Homozygous In-Frame Deletion in the Collagenous Domain of Bullous Pemphigoid Antigen BP180 (Type XVII Collagen) Causes Generalized Atrophic Benign Epidermolysis Bullosa

open access: bronze, 1997
Stéphane Chavanas   +6 more
openalex   +1 more source

Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. [PDF]

open access: yesCancer Res Commun
Hank T   +15 more
europepmc   +1 more source

Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes

open access: green, 2017
Keisuke Imafuku   +7 more
openalex   +1 more source

Alporting Trouble Down the Tubules. [PDF]

open access: yesKidney Int Rep
Chan M, Gross O.
europepmc   +1 more source

Correction to “Discovery and Functional Characterization of a Recombinant Fragment of Human Collagen Type XVII” [PDF]

open access: bronze
Lianhua Piao   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy